RSS

Research and Development (R&D)

Ubiquigent and Forma Therapeutics have entered into a multi-year strategic research and development (R&D) collaboration agreement for the design and development of novel deubiquitylase (DUB) enzyme inhibitors. more

News

Mid-sized clinical contract research organisation (CRO), TFS International, has entered into an agreement with the Pharma Intelligence division of Informa for their global research and development (R&D) platform — Citeline more

News

Pall Biotech has expanded its Hoegaarden facility in Belgium, designating it as a new strategic hub for research & development (R&D), manufacturing and customer support. more

News

Data and analytics company, GlobalData, has released its findings from its review of the biopharmaceutical industry from 2017. more

Analysis

STA Pharmaceutical, a WuXi AppTec company, has signed an oligonucleotide synthesis collaboration agreement with biopharmaceutical company, Regulus Therapeutics, for research and mid-scale non-GMP/cGMP manufacturing. more

News

Drug research and development is often likened to finding a needle in a haystack with multiple targets and many potential variables with which they can interact. So, what technological advancements are impacting development timelines… more

Opinion

A new report released by the BioIndustry Association (BIA) and Informa Pharma Intelligence has revealed that the UK has the strongest research and development (R&D) pipeline in Europe. more

Analysis

The UK BioIndustry Association (BIA) has welcomed the release of the first progress report from the AMR Industry Alliance, which has assessed the action that is being taken to tackle antimicrobial resistance (AMR). more

News

A new guide to help bioscience companies communicate R&D progress clearly and effectively to investors and the public has been released by the UK BioIndustry Association (BIA). more

News

A position paper released by the BEAM Alliance is calling for worldwide stakeholders to support small and medium-sized enterprise (SME)-driven innovation into reviving the product pipeline to fight antimicrobial resistance (AMR). more

News

Global health science marketing and communications firm, SCORR Marketing, has released a new study, in partnership with Applied Clinical Trials, evaluating the extent to which collaborations occur in the life sciences what influences them more

Analysis

Lonza has formed a new research and development (R&D) collaborative innovation centre in Israel, which is set to begin operations at the end of the year. more

News

PatSnap, a provider of research and development (R&D) analytics, has launched an online learning hub that will provide users with free courses on intellectual property (IP), PatSnap Academy. more

Technology

Cheshire-based R&D facility for new antibiotics and diagnostics, the AMR Centre, has signed a deal with US biotech company, Microbiotix, for the co-development of a bacterial virulence drug candidate. more

News

As pressure to get drugs to the human clinical trial stage increases more companies are looking to outsource not only non-core functions but major areas of R&D. Here, Praveen C. Surana, ELC Group, examines outsourcing projects in more detail. more

Opinion 1 Comments

Global healthcare logistics specialist, Yusen Logistics, has announced it is expanding its involvement in the pharma R&D supply chain after witnessing significant growth in demand for solutions from pharmaceutical manufacturers. more

Technology

Recently, there has been a shift within the pharmaceutical industry veering its R&D away from the traditional corporate campuses and moving them to new collaborative biotech clusters. Nick Sutcliffe, discusses the risks and opportunities of the trend more

Opinion

Indivior, a speciality pharmaceutical company, has opened a $30 million research and development (R&D) centre in Hull, UK, to further advance its treatment innovation into the global addiction crisis. more

News

Macrophage Pharma, an immune-oncology research and development (R&D) company that focuses on macrophage modulation in the tumour microenvironment (TME), has raised additional funding from Merck Ventures. more

News

In this instalment, R&D software provider, IDBS, lists the four considerations that are important when implementing integrated solutions. more

Opinion